Express Pharma

Accelerating GLP-1 and Therapeutic Peptide Development with Analytical Confidence

0 104

Explore practical resources designed to help peptide developers navigate analytical complexity, strengthen product understanding, and accelerate confident decisions across development and quality workflows.

Enabling Confident Peptide Development from Discovery to QC
Therapeutic peptides, including GLP-1 analogs, are rapidly advancing modern drug development but bring growing analytical complexity across characterization, impurity analysis, sequence confirmation, and bioanalysis. Due to their structural complexity, susceptibility to degradation, and the presence of multiple possible contaminants like residual solvents and synthesis by-products, analyzing peptides can be challenging. Advanced techniques such as LC/MS and HPLC are essential to support accurate analysis, product quality, and development readiness from early discovery through downstream scale-up.

This curated resource collection brings together practical guidance, workflow insights, and analytical approaches to help development teams accelerate peptide workflows with greater clarity and confidence.

Whether you are advancing GLP-1 therapeutics, optimizing peptide characterization, or strengthening bioanalytical and QC workflows, these resources are designed to support more informed analytical decisions.

🎁 Bonus Download: Receive a complimentary infographic poster illustrating complete therapeutic peptide characterization workflows from discovery to downstream readiness.

Download Now: Access the Full Resource Collection

    This is co-hosted by Express Pharma and Agilent

    By submitting this form, you are confirming you are an adult 18 years or older and agree to Express Pharma contacting you with marketing-related emails or by telephone. You may unsubscribe from receiving such communications from Express Pharma at any time. Express Pharma web sites and communications are subject to our Privacy Notice and Terms of Use.

    Yes, I would like to receive email updates about Agilent products, services and events.
    For full details of how we will treat your information please view our privacy policy: www.agilent.com/home/privacy-policy



    Leave A Reply

    Your email address will not be published.